Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Molecular Biology
Reference106 articles.
1. Recurrent ovarian cancer: how important is it to treat to disease progression?;Herzog;Clin Cancer Res,2004
2. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study;Winter;J Clin Oncol,2007
3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
4. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium;Ford;Am J Hum Genet,1998
5. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer;Tomlins;Science,2005
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma;European Journal of Cancer;2022-08
2. Identification of epigenetic genes for predicting prognosis and immunotherapy response of ovarian cancer;Japanese Journal of Clinical Oncology;2022-04-18
3. Epigenetic biomarker and drug development in gynecological cancers;Epigenetics in Precision Medicine;2022
4. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma;Medicine;2021-10-08
5. Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model;Acta Biomaterialia;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3